Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 2
1973 1
1974 1
1976 1
1978 1
1980 1
1982 3
1983 3
1985 2
1986 4
1987 1
1988 4
1989 3
1990 5
1991 2
1992 8
1993 16
1994 7
1995 11
1996 7
1997 10
1998 9
1999 16
2000 9
2001 7
2002 11
2003 11
2004 15
2005 18
2006 25
2007 25
2008 27
2009 25
2010 27
2011 35
2012 40
2013 55
2014 48
2015 61
2016 74
2017 63
2018 63
2019 64
2020 84
2021 94
2022 91
2023 95
2024 111

Text availability

Article attribute

Article type

Publication date

Search Results

1,169 results

Results by year

Filters applied: . Clear all
Page 1
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial.
Olivotto I, Oreziak A, Barriales-Villa R, Abraham TP, Masri A, Garcia-Pavia P, Saberi S, Lakdawala NK, Wheeler MT, Owens A, Kubanek M, Wojakowski W, Jensen MK, Gimeno-Blanes J, Afshar K, Myers J, Hegde SM, Solomon SD, Sehnert AJ, Zhang D, Li W, Bhattacharya M, Edelberg JM, Waldman CB, Lester SJ, Wang A, Ho CY, Jacoby D; EXPLORER-HCM study investigators. Olivotto I, et al. Among authors: hegde sm. Lancet. 2020 Sep 12;396(10253):759-769. doi: 10.1016/S0140-6736(20)31792-X. Epub 2020 Aug 29. Lancet. 2020. PMID: 32871100 Clinical Trial.
An IL-4 signalling axis in bone marrow drives pro-tumorigenic myelopoiesis.
LaMarche NM, Hegde S, Park MD, Maier BB, Troncoso L, Le Berichel J, Hamon P, Belabed M, Mattiuz R, Hennequin C, Chin T, Reid AM, Reyes-Torres I, Nemeth E, Zhang R, Olson OC, Doroshow DB, Rohs NC, Gomez JE, Veluswamy R, Hall N, Venturini N, Ginhoux F, Liu Z, Buckup M, Figueiredo I, Roudko V, Miyake K, Karasuyama H, Gonzalez-Kozlova E, Gnjatic S, Passegué E, Kim-Schulze S, Brown BD, Hirsch FR, Kim BS, Marron TU, Merad M. LaMarche NM, et al. Among authors: hegde s. Nature. 2024 Jan;625(7993):166-174. doi: 10.1038/s41586-023-06797-9. Epub 2023 Dec 6. Nature. 2024. PMID: 38057662 Free PMC article. Clinical Trial.
Hematopoietic aging promotes cancer by fueling IL-1⍺-driven emergency myelopoiesis.
Park MD, Le Berichel J, Hamon P, Wilk CM, Belabed M, Yatim N, Saffon A, Boumelha J, Falcomatà C, Tepper A, Hegde S, Mattiuz R, Soong BY, LaMarche NM, Rentzeperis F, Troncoso L, Halasz L, Hennequin C, Chin T, Chen EP, Reid AM, Su M, Cahn AR, Koekkoek LL, Venturini N, Wood-Isenberg S, D'souza D, Chen R, Dawson T, Nie K, Chen Z, Kim-Schulze S, Casanova-Acebes M, Swirski FK, Downward J, Vabret N, Brown BD, Marron TU, Merad M. Park MD, et al. Among authors: hegde s. Science. 2024 Sep 5:eadn0327. doi: 10.1126/science.adn0327. Online ahead of print. Science. 2024. PMID: 39236155
Evaluation of Mavacamten in Symptomatic Patients With Nonobstructive Hypertrophic Cardiomyopathy.
Ho CY, Mealiffe ME, Bach RG, Bhattacharya M, Choudhury L, Edelberg JM, Hegde SM, Jacoby D, Lakdawala NK, Lester SJ, Ma Y, Marian AJ, Nagueh SF, Owens A, Rader F, Saberi S, Sehnert AJ, Sherrid MV, Solomon SD, Wang A, Wever-Pinzon O, Wong TC, Heitner SB. Ho CY, et al. Among authors: hegde sm. J Am Coll Cardiol. 2020 Jun 2;75(21):2649-2660. doi: 10.1016/j.jacc.2020.03.064. J Am Coll Cardiol. 2020. PMID: 32466879 Free article. Clinical Trial.
Mavacamten Treatment for Symptomatic Obstructive Hypertrophic Cardiomyopathy: Interim Results From the MAVA-LTE Study, EXPLORER-LTE Cohort.
Rader F, Oręziak A, Choudhury L, Saberi S, Fermin D, Wheeler MT, Abraham TP, Garcia-Pavia P, Zwas DR, Masri A, Owens A, Hegde SM, Seidler T, Fox S, Balaratnam G, Sehnert AJ, Olivotto I. Rader F, et al. Among authors: hegde sm. JACC Heart Fail. 2024 Jan;12(1):164-177. doi: 10.1016/j.jchf.2023.09.028. JACC Heart Fail. 2024. PMID: 38176782 Free article. Clinical Trial.
Not a Hydrocele!
Hegde S, Jadhav V, Shankar G. Hegde S, et al. J Pediatr. 2018 Jun;197:311. doi: 10.1016/j.jpeds.2018.01.011. Epub 2018 Mar 1. J Pediatr. 2018. PMID: 29502879 No abstract available.
SUMO conjugation regulates immune signalling.
Hegde S, Soory A, Kaduskar B, Ratnaparkhi GS. Hegde S, et al. Fly (Austin). 2020 Mar-Dec;14(1-4):62-79. doi: 10.1080/19336934.2020.1808402. Epub 2020 Aug 31. Fly (Austin). 2020. PMID: 32777975 Free PMC article. Review.
Microbial control of arthropod-borne disease.
Saldaña MA, Hegde S, Hughes GL. Saldaña MA, et al. Among authors: hegde s. Mem Inst Oswaldo Cruz. 2017 Feb;112(2):81-93. doi: 10.1590/0074-02760160373. Mem Inst Oswaldo Cruz. 2017. PMID: 28177042 Free PMC article. Review.
Peripheral 5-HT4 receptors.
Hegde SS, Eglen RM. Hegde SS, et al. FASEB J. 1996 Oct;10(12):1398-407. doi: 10.1096/fasebj.10.12.8903510. FASEB J. 1996. PMID: 8903510 Review.
1,169 results